%0 Journal Article %A Evija Livcane %A Edite Fridrihsone %T Immunological status of TB/HIV dual infection patients in Latvia in year 2009 %D 2011 %J European Respiratory Journal %P p2723 %V 38 %N Suppl 55 %X In the world tuberculosis (TB) is main cause of illness and death for human immunodeficiency virus (HIV) patients. Situation among TB/HIV dual infection patients in Latvia is relatively unexplored.Aims: To analyse:incidence of various TB clinical forms among HIV patients;incidence of resistant TB among TB/HIV patients;medium immunological parameters for TB/HIV patients at the moment of TB diagnosis;anti-TB therapy results for HIV/TB patients.Materials and methods: In retrospective study case histories for 61 from 73 patients diagnosed in year 2009 with TB/HIV dual infection were analysed.Results: For 72% (43) patients HIV was diagnosed before TB diagnosis, 28% (17) patients HIV and TB were diagnosed simultaneously. In 80% (49) TB was diagnosed for firs time, in 20% (12) relapse. In 40% (25) multiorgan TB infection was diagnosed, in 30% (18) infiltrative pulmonary TB, in 25% (15) disseminated pulmonary TB and in 5% (3) extra pulmonary TB. In 60% (37) cases TM was sensitive to all antiTB drugs, in 35% (21) resistant cases. Medium CD4+ cell count at the moment of TB diagnosis was 294 cells/mm3 (min–6,max–2003). 67% (41) patients received full,18% (11) disrupted therapy and 13% (9) cases were lethal.Conclusion: In year 2009 significant number of TB and HIV were diagnosed simultaneously. Pulmonary TB dominates among TB/HIV patients, but there is also high number of patients with TB multi-organ infection. There is high number of resistant TB among HIV/TB infected individuals. High CD4+ cell count could indicate high incidence of TB among HIV/TB individuals. There is significant number of cases where TB is cause of death in TB/HIV dual infection patients. %U